Objective: To examine the effects of a mechanical ventilation weaning management protocol that was implemented as a hospital-wide, quality improvement program on clinical and economic outcomes.
T hroughout the past decade, acute care hospitals have experienced increasing financial difficulties. Expenses have increased because of the rising costs of medications, diagnostic testing, equipment, supplies, and labor, coupled with inefficiencies in work processes (1) . Medi-care, Medicaid, and virtually all private insurers have sought to reduce their expenses by carefully scrutinizing payments to hospitals, slowing their rates of increase, and reducing payments whenever possible. These agencies view critical care services as a potentially important source of savings because of the enormous cost of providing care to the critically ill. It has been estimated that because health care consumes 14% of the gross domestic product and critical care generates 8% of healthcare costs, critical care services make up Ͼ1% of the gross domestic product (2) .
The financial and clinical resources consumed in the intensive care unit (ICU) are distributed unevenly. ICU patients who require Ͼ3 wks of mechanical ventilation (MV) are responsible for a large percentage of the ICU days used and the dollars spent. Despite the fact that these patients represent only 10% of patients cared for in ICUs and only 9% to 20% of the patients who required MV, they consumed approximately 50% of ICU resources (2) . This imbalance can be illustrated by looking at the service intensity weight, which is a value calculated to reflect the relative resource consumption associated with a diagnosisrelated group (DRG) (3) . The service intensity weight for patients who undergo tracheostomy, which includes many of the patients who receive MV for Ͼ3 wks, is secondary only to the service intensity weight of heart, liver, and lung transplants (3) . In addition to its economic consequences, it is well established that prolonged MV is an impediment to ensuring quality care because it predisposes to local and systemic complications and death (4) . On the other hand, failed extubation, possibly caused by per-forming the process too soon, carries its own adverse prognosis (5) .
In the mid-1990s, based on information generated by University HealthSystem Consortium, the University of Massachusetts Medical Center (now part of UMass Memorial Healthcare) estimated that its cost for taking care of patients who received MV was $6 million in excess of similar costs for the University Health-System Consortium's "best performing" institutions. The excess cost was due to excessive length of hospital stay and duration of MV. The costs were generated by patients in two DRGs: DRG 475, "Respiratory system diagnosis with mechanical ventilation," and DRG 483, "Tracheotomy except for mouth, laryngeal, or pharyngeal disorder."
In 1995, 23 individuals on the Ventilator Management Team, which included physicians and nurses from medicine, surgery, and anesthesia, respiratory care practitioners, quality management personnel, and hospital administrators, assembled to devise a strategy to deal with the situation described above. This was the first large-scale, truly multidisciplinary provider-driven cost and quality improvement project for our institution. The goals of this project were to improve patient care and to reduce costs by reducing hospital length of stay (LOS), ventilator days, tracheotomies performed, and hospital costs for ventilator-dependent patients. This report is presented as an example of hospital system change, and it describes the clinical and economic outcomes that resulted from this process. We extensively describe the program development process because we believe it is essential to understanding the nature of the program.
MATERIALS AND METHODS

Weaning Practices in the Baseline Year.
During the baseline year, weaning was performed in the manner prescribed by the individual attending physician. Various modes of weaning, which included spontaneous breathing trials using a T-piece, continuous positive airway pressure (CPAP), synchronized intermittent mandatory ventilation, and pressure support ventilation, were used. Throughout that year, there was no standardization of care.
Program Development Process. The Ventilator Management Team first decided on a limited number of major principles with which to guide the care of patients. These four principles were derived from clinical experience and were based on the best available evidence from the literature. a) Patients do not successfully wean from a ventilator because of a specific mode of weaning. They wean from a ventilator if and when they receive appropriate medical care. b) Patients remain on prolonged MV because of fatigue or weakness of the inspiratory muscles; therefore, medical care must address and overcome barriers that increase demand on these muscles and/or prevent them from getting stronger. c) The weaning process should begin as soon as the condition that caused the respiratory failure is stabilized and the patient begins to improve. d) A single mode of weaning should be used throughout the hospital, and it should provide adequate patient monitoring, involve fewer decision points, and reduce the labor required of respiratory therapists and nurses.
After unanimous acceptance of these principles, the Ventilator Management Team decided on the following program of action: a) to standardize the weaning process throughout the institution; b) to develop and institute a standardized weaning protocol and a multitiered system for caring for all ventilatordependent patients; and c) to continuously monitor adherence to the protocol and to encourage healthcare providers to follow the program if and when they deviate from it. The core operational elements of the program were then determined. a) A once-daily trial of spontaneous breathing was chosen to be the weaning mode throughout the acute care hospital. This technique used a CPAP of 5 cm H 2 O on Puritan-Bennett 7200a ventilators (Nellcor Puritan Bennett, Pleasanton, CA), modified with the "flow-by" system. The duration of the trial was not time-limited but based on objective criteria for weaning failure listed below.
b) The actual weaning process was defined and is shown in Figure 1 . Criteria that indicated the success of an initial 5-min trial were a respiratory rate between 8 and 35 breaths/ min, a spontaneous tidal volume of Ͼ2 mL/kg, a respiratory rate/tidal volume ratio of Ͻ100, and a minute ventilation of Ͻ15 L/min. If all of these variables were satisfied, the patients remained on CPAP until they were extubated (in the cases of patients with tracheostomies, a change from CPAP to trach collar with humidified oxygen was considered equivalent to extubation) or they demonstrated signs of respiratory failure. Criteria for failure at any time on CPAP included diaphoresis, new atrial or ventricular arrhythmias, apnea Ͼ45 secs, the inability to maintain oxyhemoglobin saturation at Ն90% on an FIO 2 of Յ0.6, systolic blood pressure changes of Ͼ15 mm Hg decrease or 20 mm Hg increase, breathlessness or fatigue measured at Ͼ7/10 on the Modified Figure 1 . Schematic representation of the weaning assessment and continuous positive airway pressure (CPAP) trial process. FIO 2 , fraction of inspired oxygen; VE, minute ventilation; Cst, static respiratory system compliance; RRT, registered respiratory therapist; FIP, forced inspiratory pressure. Borg Category Scale, or physician, nurse, or therapist assessment of failure. When one or more of these signs was seen, the patient was returned to the ventilator at settings designed to provide full support of ventilation and to allow maximum muscle rest. If none of the objective criteria for failure were met, patients remained on CPAP until they were extubated or tracheotomized patients were changed to trach masks. c) A list of common medical barriers to weaning was created ( Table 1) . A standardized approach to each of these barriers was developed.
d) The personnel makeup of the day-to-day care team was resolved. The program was directed and monitored on a daily basis by a pulmonary and critical care specialist (RSI) and coordinated by two pulmonary nurses. One nurse was referred to as the weaning coordinator (AC) and was responsible for patient identification and evaluation and staff education. The weaning coordinator followed up all patients who had received 2 wks of MV, those who received MV for 7 days after acute surgical issues were resolved, or those who had failed to wean after 72 hrs of attempts. The other nurse, referred to as the case manager, was responsible for coordination of care and transfer to the extramural subacute ventilator unit at an acute rehabilitation hospital (Fairlawn Rehabilitation Hospital, Worcester, MA). e) Patient flow through our system was facilitated in multiple ways.
• Patients who were not in the medical ICU had a consultation with a weaning specialist (e.g., pulmonary medicine) after 3 days of failed weaning attempts. • Patients were considered for transfer to the medical ICU as soon as a bed became available if they had not weaned within 7 days after their acute surgical issues were resolved. • Patients were considered for transfer to the extramural ventilator unit when their attending physicians believed them to be stable, when the medical barriers to their weaning had been addressed, and when weaning was considered unlikely in the next 7 days. • Activities in the acute and rehabilitation hospitals were integrated by having pulmonary and critical care medicine physicians from our institution provide care at both sites.
f) An intensive schedule of educational sessions was initiated. In addition to the formal sessions provided to ICU nurses, respiratory care practitioners, medical and surgical housestaff, and attending physicians, individual meetings were held with attending physicians who were not directly involved in the ventilator management team but whose patients would be affected by the protocol. A schedule of continuing educational sessions was devised. Caregivers who joined our system after the implementation phase were scheduled for one of these sessions. g) Clinical, fiscal, and utilization data were collected and reviewed for patients in DRG 475 (the nontrached group), DRG 483 (the trached group), and DRGs 475 and 483 (combined group). Fiscal and utilization data were collected prospectively by the hospital and provided to the ventilator management team in the form of quarterly and annual reports. The following information was provided for each DRG and for the two combined DRGs: the names and numbers of patients; average age; ICU LOS; ventilator days; mean and median hospital LOS; mortality; and total cost per case. The remaining data were collected from the Meditech Hospital Information System (Medical Information Technology, Westwood, MA) and from the medical records.
h) The following outcomes were analyzed among patients in each of the groups and in the two groups taken together: days on MV; mean and median hospital LOS; ICU LOS; hospital costs; hospital mortality; discharge destination; the percentage of patients requiring tracheostomy; the percentage of patients requiring multiple courses of MV; and the number of days before beginning weaning.
i) Severity of illness was compared by calculating the Acute Physiology and Chronic Health Evaluation (APACHE) II scores for each patient and then tabulating them for each DRG and for the combined group each year. j) An executive committee of the ventilator management team met at least twice yearly to review data, to identify problems, and to recommend solutions to any problems encountered in the implementation of the program.
Statistical Analysis. Statistical analyses were performed with a computerized statistical package (SPSSx 9.0 for Windows, Chicago, IL). Both the nonparametric Kruskal-Wallis H test and the one-way analysis of variance were used to compare continuous variables between the 3 yrs of data. Because there was no substantial difference in the results between these two methods, (i.e., no significant data effect from outliers), only the results of the one-way analysis of variance are reported here. Categorical variables were compared by chi-square testing. A p value of Յ.05 was considered statistically significant. Post hoc tests for multiple comparisons were performed using Tukey's Honestly Significant Differences Test of contrasts among all possible pairings.
RESULTS
Characteristics of Patients.
A summary of the salient characteristics of our patients is provided in Table 2 . Complete information was available for 734 of 738 (99.5%) patients. Although the total number of patients in DRGs 475 and 483 increased in year 1 and year 2 compared with year 0, this increase was accounted for solely by an increase of the number of patients in the nontrached group. Associated with this is a significant shift in the proportion of patients in each DRG, with the increase in the nontrached group from 86 to 156 accompanied by a decrease in the trached group from 134 to 111 (p Ͻ .0005). Severity of illness measured by APACHE II was significantly higher in the first year of implementation (year 0 vs. year 1; p ϭ .006) and was higher again in the second implementation year (year 1 vs. year 2, p ϭ .025; year 0 vs. year 2, p Ͻ .0005). Pearson correlation analysis indicated a weak but statistically significant correlation between the increase in APACHE II score and the shift in DRG distribution over time (r ϭ .288; p ϭ .01) toward DRG 475, which reflects a shorter duration of MV. There was no significant difference in age or gender distribution. The reasons for respiratory failure showed a change during the 3 yrs. When "post-op" is defined as the continuous need for MV after surgery and "pneumonia" is defined to include both community-acquired and nosocomial cases, there were significantly fewer post-op cases and significantly more cases of respiratory failure attributable to pneumonia (both p Ͻ .0005) in year 2 of implementation compared with year 0.
ICU and Hospital Utilization and Financial Outcomes. Data for DRGs 475, 483, and 475 combined with 483 are summarized in Tables 3-5 . Data that reflect the overall impact of the program on hospital utilization and financial outcomes appear in Table 5 . Table 3 shows that the mean APACHE II score for patients in the nontrached group increased over time from 22.5 Ϯ 6.8 to 26.1 Ϯ 8.6 (p ϭ .005). There was no significant change in ventilator days, hospital LOS, ICU LOS, total cost per case, or aggregate total cost. Table 4 shows that the APACHE II scores for patients in the trached group increased from 21.9 Ϯ 7.8 to 26.3 Ϯ 6.3 . When year 0 is compared with year 1, significant improvements are seen in hospital and ICU LOS (p ϭ .014 and .035, respectively). Trends toward improvement are also seen in mean and median ventilator days, total cost, and total cost per case. When year 0 is compared with year 2, significant improvements are seen in mean ventilator days per patient (23.9 Ϯ 22.0 to 17.5 Ϯ 17.2; p ϭ .004), mean hospital LOS (37.5 Ϯ 31.6 to 24.7 Ϯ 20.6; p Ͻ .0005), ICU LOS (30.5 Ϯ 28.7 to 20.3 Ϯ 18.5; p Ͻ .0005), and total cost per case ($92,933 Ϯ $5,381 to $63,687 Ϯ $3,839; p Ͻ .0005). During the same interval, the mean decrease in hospital LOS for the entire hospital across the full spectrum of DRGs was 0.7 days (6.5-5.8 days). Total hospital cost for these two DRGs was Ͼ$3.4 million less in the second year of the program.
Clinical Outcomes. Table 6 summarizes the impact of the weaning program on clinical outcomes. There was a significant reduction in the percentage of cases involving tracheotomy, defined as DRG 483/DRG 483 ϩ DRG 475 (61% to 42%; p Ͻ .0005). There was also a decline in the percentage of cases involving reintubation, defined as the percentage of patients who required more than one course of MV during their hospitalization (33% to 26%; p ϭ .039). There was a nonsignificant trend toward reduction in ICU and hospital mortality. There were no significant differences in the destinations at discharge (home vs. continuing care facilities).
DISCUSSION
This report describes a novel quality improvement program that is focused on weaning patients from MV, and it outlines the effects that can be associated with the implementation of such a program. The program was novel for several reasons. It was multifaceted because it addressed the lengthy series of processes involved in weaning from MV and discharge from the hospital. It was multidisciplinary because representatives of many departments participated on the initial ventilator management team and because the skills of bedside nurses, respiratory care practitioners, and physicians were all essential in making it work. It was distinctive because it focused on standardizing and improving the medical care of the difficult-to-wean patient, rather than focusing on a weaning mode or technique. It was unique because the magnitude of the improvement seen in patients was greater than any previously reported and because the improvements were maintained for a longer period than previously reported. On the basis of our results, we have shown that a multifaceted, multidisciplinary, acute care hospital-wide weaning program can be associ- ated with significant improvements in ICU and hospital utilization, cost reduction, and clinical outcomes, even when the severity of illness of patients is increasing.
ICU and Hospital Utilization. The utilization of MV, hospital beds, and ICU beds improved as reflected by the reduction in days on MV, hospital LOS, and ICU LOS. These are the largest utilization improvements generated by a weaning pro-gram reported to date. These increases occurred despite a concurrent statistically significant increase in the severity of illness of our patients, as indicated by the increase in the mean APACHE II score from 22.2 to 26.2 (p Ͻ .0005) at the time of ICU admission (Tables 2 and 5). We believe that the program allowed us to deal with this severely ill group of patients more effectively, thereby hastening their liberation from MV.
The mean reduction in the duration of MV seen in our entire group from year 0 to year 2 (6.4 days; p ϭ .004) compares favorably with the reductions seen in other studies (6 -9) . Many of these other reports measured improvement in hours, whereas the improvement seen in our study nearly equaled 1 wk. We believe that this reduction was owing to several factors, which included the following: a) the long duration of MV seen at the start of the project; b) a systematic approach to the medical care of the ventilated patient; and c) an organized and aggressive system that transferred patients to the appropriate physician and site of care. One example of how the systematic approach may have improved our weaning process was seen in the trend toward earlier weaning (7.9 -6.8 days; p ϭ .153) ( Tables  6 and 7) .
Mean LOS in the acute care hospital (37.5-24.7 days; p Ͻ .0005) and in the ICU (30.5-20.3 days; p ϭ .004) were also significantly improved between year 0 and year 2 ( Table 5 ). Improvement was first seen in interim reports in as early as 3 months (10). By comparison, the LOS for our entire hospital (all DRGs) decreased from 6.5 to 5.8 days during the same interval. Our 271 patients accounted for 33% of the total reduction in LOS for the entire hospital (3469/10288 days saved based on 14,697 patient discharges). These findings have not been consistently found or reported elsewhere. Other reports of weaning programs either did not report changes in hospital LOS (7, 9, 11) or they reported improvements that did not achieve statistical significance (6, 12) . Similarly, although a few other reports have shown significant reductions in ICU LOS (8, 12) , others have shown no differences (13) , and the majority have not addressed this issue (6, 7, 9, 11) . As is the case with the improvements in duration of MV discussed above, we believe that the systematic approach to the medical care of the ventilated patient and an organized and aggressive care management system worked together to create the improvements we realized. As a byproduct of these improvements in bed utilization, we were able to handle a larger volume of patients during the program implementation years (Tables 2 and 5), despite no increase in the number of ICU beds.
Cost Reduction. Because of the reduction in days on MV and hospital LOS, our program appears to have generated substantial cost reductions. The reductions in cost per case of $14,309 and $29,246 for years 1 and 2, respectively, translated into total cost savings of $1,025,277 and $3,440,787 for those particular years ( Table  5 ). We also considered what the opportunity cost would have been if the program had not been implemented. If the cost per case from year 0 were multiplied by the total number of cases in year 2, then the projected total cost would have been $24,813,111. This figure is $7,808,556 more than was actually spent. Alternatively, if we had achieved our cost savings per case but had not increased our caseload, our projected expenditures would have been $14,011,140 ($63,687 ϫ 220). This amount is $6,434,202 less than was actually spent for the same number of patients in year 0. By contrast, other studies that looked at the economic effects of weaning programs found a cost-per-case reduction of $2819 or a total cost savings of $603,580 (8, 13) .
Clinical Outcomes. Despite the increase in the severity of illness that we saw, the ICU and hospital mortality for our patients had a downward trend (Table 6 ). There was also a reduction in the percentage of patients in DRG 483 ( Table 2 ). The shift in DRG distribution was correlated significantly with the increase in severity of illness reflected by APACHE II scores (r ϭ .288; p ϭ .01). We believe that this occurred because our program facilitated more rapid weaning and patients moved through their hospitalization faster and required fewer tracheotomies. By producing an increase in its available bed capacity, the program also allowed us to admit a greater number of more acutely ill patients. At the same time, there was a reduction in the number of patients who required reintubation (Table 6 ) and additional courses of MV during their hospitalization. Although our study was not designed to offer an explanation for this finding, we speculate that the reduction in reintubation percentage was the result of two components of our program. First, because of the long duration of intubation of some patients and because it has been shown that mortality is increased among reintubated patients, we did not routinely attempt extubation at 2 hrs but allowed observation periods on CPAP of up to 24 hrs for some patients. Second, during years 1 and 2, we systematically identified and treated factors that perpetuated fatigue of the respiratory muscles. We believe that the improved treatment of barriers to weaning coupled with the long CPAP trials may explain the decrease in reintubation percentage. These factors may be particularly important because of the prolonged duration of critical illness in many of these patients.
Consideration of Alternative Explanations of Our Outcomes. The results seen could be explained several ways. First, they may be partly or completely attributable to this program. Second, they could be a result of shifting the LOS and cost burden to another institution. Third, they could be partly or completely attributable to other factors that occurred among these patients at the same time that this program was operational.
For a variety of reasons, we believe that the results we observed were primarily owing to the impact of our program. The program combined two approaches that have been shown in the literature to improve the weaning process: a) the institution of a ventilator management team (12) ; and b) protocol-directed weaning (6, 8, 9, 13, 14) . The "weaning team" has the advantage of focusing on weaning exclusively. Protocol-directed care prevents delays in the initiation of weaning, reduces the number of potential decision points, and helps a group of caregivers develop expertise in a specific method of weaning. With the incorporation of the above two concepts into our program design, we believe that our program possesses the ingredients that have been proven necessary for success.
In addition to these concepts, the weaning program made use of several techniques that have been proven to favorably influence physician behavior. Respected opinion leaders from many departments were enlisted for key participation (15) . We provided constant, consistent, and concurrent individual follow up and reinforcement of the protocol after its implementation (16) . Repetitive and mechanical tasks were taken out of the hands of physicians by empowering nurses and respiratory therapists to facilitate work flow. Moreover, our program carried an indirect monetary incentive for physicians by increasing the potential for caring for additional revenue-generating patients through the improvement of bed utilization (16) .
We do not believe that the results presented here are primarily the result of cost shifting. There was only a small increase in the percentage of patients transferred to acute rehabilitation during the 3 yrs (38% to 42%; p ϭ NS). In addition, only 26 of the 112 patients transferred in year 2 were still receiving MV. On the other hand, we do acknowledge that some portion of acute care hospital utilization and cost was transferred to acute rehabilitation hospitals because the program was designed to do so. Keeping postacute patients in the ICU beyond the time of their need for critical care is inappropriate and potentially dangerous. In addition, costs may be more easily controlled in the acute rehabilitation environment (4, 17) . This is at least in part because fewer hours of nursing care per patient are provided in acute rehabilitation (18) . We made a concerted effort to ensure that patients discharged to postacute rehabilitation received appropriate care. That effort led us to establish our own service, staffed by our own pulmonary/critical care physicians, at a local rehabilitation hospital. We feel that one of the strengths of the program is that our own physicians are personally involved in the posthospital care of these critical illness survivors. This approach has been advocated elsewhere (18) .
We also do not believe that the outcomes reported here were the result of other factors that occurred in our hospital at the same time as this program. No other major quality-and cost-improvement programs were directed at these patients at the time of this program. Although there was a move toward instituting case management services throughout our hospital at that time, the reduction in LOS for our entire hospital was only 0.7 days. Nevertheless, we acknowledge that we probably benefited from the "Hawthorne effect," inherent in any such project. This term implies that participating in a project such as ours, with the knowledge that performance is being observed and recorded, will affect behavior and outcomes. In most cases, the implication is that the improvements realized will be lost when such attention is no longer focused on the study group; however, we believe that it is always appropriate to focus attention on highvolume, high-cost, high-mortality patients. We have no intention of ceasing to focus on these patients. Two aspects of our statistical analysis deserve comment. First, we performed our statistical analysis from the perspective of how our program affects the patient and the acute care hospital. Because our program was designed to improve the operations of our acute care hospital, analyzing and reporting our data this way is consistent with the original goals of our program. In addition, outcome information generated after the patients were discharged from the acute care hospital was not available to us because the patients were discharged to many different locations. This makes it impossible to quantify the impact of our program on global medical costs as they affect society. Second, because our program included several different interventions applied simultaneously, we have taken the approach that the program as a whole was an intervention and its impact was analyzed. This approach prevents us from determining whether one component of the program was responsible for most of the benefit seen. Notwithstanding, our methodology is consistent with our philosophy that a comprehensive approach to weaning and discharge is necessary to maximize the performance of our institution.
Perspective. This program has created a paradigm shift in the minds of our healthcare team regarding what is most important in weaning patients from MV. We no longer focus on what the "best" mode of weaning is. Rather, our focus has turned to the identification of problem patients, the management of barriers to weaning, and the elimination of impediments to timely extubation and discharge. By making this change, we have been able to generate large improvements in LOS, duration of MV, and cost. Our results contain an important message for investigators trying to determine which weaning mode (i.e., pressure support ventilation, synchronized intermittent mandatory ventilation, or spontaneous breathing trials) is best. Until protocols that address medical barriers to weaning are standardized within and between institutions participating in a clinical trial, it will not be possible to fairly compare the different weaning modes.
